» Articles » PMID: 38632473

Cellular Geometry and Epithelial-mesenchymal Plasticity Intersect with PIEZO1 in Breast Cancer Cells

Overview
Journal Commun Biol
Specialty Biology
Date 2024 Apr 17
PMID 38632473
Authors
Affiliations
Soon will be listed here.
Abstract

Differences in shape can be a distinguishing feature between different cell types, but the shape of a cell can also be dynamic. Changes in cell shape are critical when cancer cells escape from the primary tumor and undergo major morphological changes that allow them to squeeze between endothelial cells, enter the vasculature, and metastasize to other areas of the body. A shift from rounded to spindly cellular geometry is a consequence of epithelial-mesenchymal plasticity, which is also associated with changes in gene expression, increased invasiveness, and therapeutic resistance. However, the consequences and functional impacts of cell shape changes and the mechanisms through which they occur are still poorly understood. Here, we demonstrate that altering the morphology of a cell produces a remodeling of calcium influx via the ion channel PIEZO1 and identify PIEZO1 as an inducer of features of epithelial-to-mesenchymal plasticity. Combining automated epifluorescence microscopy and a genetically encoded calcium indicator, we demonstrate that activation of the PIEZO1 force channel with the PIEZO1 agonist, YODA 1, induces features of epithelial-to-mesenchymal plasticity in breast cancer cells. These findings suggest that PIEZO1 is a critical point of convergence between shape-induced changes in cellular signaling and epithelial-mesenchymal plasticity in breast cancer cells.

Citing Articles

Influence of cell shape on sonoporation efficiency in microbubble-facilitated delivery using micropatterned cell arrays.

Baig M, Du Y, Zan Z, Fan Z Sci Rep. 2024; 14(1):30845.

PMID: 39730459 PMC: 11680583. DOI: 10.1038/s41598-024-81410-1.

References
1.
Denais C, Gilbert R, Isermann P, McGregor A, Te Lindert M, Weigelin B . Nuclear envelope rupture and repair during cancer cell migration. Science. 2016; 352(6283):353-8. PMC: 4833568. DOI: 10.1126/science.aad7297. View

2.
Monteith G, Prevarskaya N, Roberts-Thomson S . The calcium-cancer signalling nexus. Nat Rev Cancer. 2017; 17(6):367-380. DOI: 10.1038/nrc.2017.18. View

3.
Duffy M, McGowan P, Harbeck N, Thomssen C, Schmitt M . uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Res. 2015; 16(4):428. PMC: 4423643. DOI: 10.1186/s13058-014-0428-4. View

4.
Burks H, Matossian M, Rhodes L, Phamduy T, Elliott S, Buechlein A . ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism. Breast Cancer Res Treat. 2021; 189(1):25-37. DOI: 10.1007/s10549-021-06256-x. View

5.
Holt J, Zeng W, Evans E, Woo S, Ma S, Abuwarda H . Spatiotemporal dynamics of PIEZO1 localization controls keratinocyte migration during wound healing. Elife. 2021; 10. PMC: 8577841. DOI: 10.7554/eLife.65415. View